{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:23:19Z","timestamp":1778887399802,"version":"3.51.4"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703626"],"award-info":[{"award-number":["81703626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773995"],"award-info":[{"award-number":["81773995"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973562"],"award-info":[{"award-number":["81973562"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073948"],"award-info":[{"award-number":["82073948"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.intimp.2020.107328","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T20:16:57Z","timestamp":1610223417000},"page":"107328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["An insight into the mechanism and molecular basis of dysfunctional immune response involved in cholestasis"],"prefix":"10.1016","volume":"92","author":[{"given":"Mengzhi","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1665-2681(19)31949-0","article-title":"Biliary secretion and excretion in health and disease: current concepts","volume":"6","author":"Hofmann","year":"2007","journal-title":"Ann. Hepatol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","article-title":"Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes","volume":"12","author":"Asai","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0034-1375962","article-title":"Drug-induced liver injury and drug development: industry perspective","volume":"34","author":"Regev","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.intimp.2020.107328_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012546","article-title":"Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy","author":"Manzotti","year":"2017","journal-title":"Cochrane Database of Systematic Rev."},{"key":"10.1016\/j.intimp.2020.107328_b0025","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30841","article-title":"Plectin mutations in progressive familial intrahepatic cholestasis","author":"Wu","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2020.107328_b0030","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.29540","article-title":"C\/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice","volume":"67","author":"Liu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2020.107328_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.10.016","article-title":"Protective effects of SRT1720 via the HNF1alpha\/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury","volume":"264","author":"Yu","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.intimp.2020.107328_b0040","doi-asserted-by":"crossref","first-page":"33052","DOI":"10.1038\/srep33052","article-title":"Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"issue":"7785","key":"10.1016\/j.intimp.2020.107328_b0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2020.107328_b0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcp.2019.06.009","article-title":"Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis","volume":"168","author":"Razori","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/toxsci\/kfj111","article-title":"Early growth response factor-1 is critical for cholestatic liver injury","volume":"90","author":"Kim","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.intimp.2020.107328_b0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-230X-13-79","article-title":"Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis","volume":"13","author":"Jin","year":"2013","journal-title":"BMC Gastroenterol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clinre.2018.06.009","article-title":"Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience","volume":"42","author":"Lemoinne","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dld.2016.10.006","article-title":"Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: results in real-world conditions and factors predictive of response to treatment","volume":"49","author":"Bacq","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.intimp.2020.107328_b0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/164_2019_241","article-title":"UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications","volume":"256","author":"Cabrera","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0080","first-page":"73","article-title":"Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis","volume":"27","author":"Yuan","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.intimp.2020.107328_b0090","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0095","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","article-title":"Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis","volume":"60","author":"Wunsch","year":"2014","journal-title":"Hepatology"},{"issue":"10201","key":"10.1016\/j.intimp.2020.107328_b0100","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","article-title":"Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0105","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/14767058.2017.1300652","article-title":"Expression and significance of dendritic cells and Th17\/Treg in serum and placental tissues of patients with intrahepatic cholestasis of pregnancy","volume":"31","author":"Kong","year":"2018","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"issue":"4","key":"10.1016\/j.intimp.2020.107328_b0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2018.09.035","article-title":"PPARgamma provides anti-inflammatory and protective effects in intrahepatic cholestasis of pregnancy through NF-kappaB pathway","volume":"504","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2020.107328_b0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.reprotox.2017.08.002","article-title":"Cholestatic pregnancy is associated with reduced VCAM1 expression in vascular endothelial cell of placenta","volume":"74","author":"Qin","year":"2017","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.intimp.2020.107328_b0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1755-8794-7-42","article-title":"Placental gene-expression profiles of intrahepatic cholestasis of pregnancy reveal involvement of multiple molecular pathways in blood vessel formation and inflammation","volume":"7","author":"Du","year":"2014","journal-title":"BMC Med. Genomics"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/cmi.2015.86","article-title":"The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis","volume":"14","author":"Tomiyama","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2020.107328_b0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.taap.2016.10.011","article-title":"UDCA and CDCA alleviate 17alpha-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats","volume":"311","author":"Li","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107328_b0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fphar.2017.00256","article-title":"SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model","volume":"8","author":"Yu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107328_b0155","doi-asserted-by":"crossref","first-page":"7657294","DOI":"10.1155\/2019\/7657294","article-title":"Overexpression of Tumor Necrosis Factor-Like Ligand 1 A in Myeloid Cells Aggravates Liver Fibrosis in Mice","volume":"2019","author":"Guo","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0160","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.29838","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans","volume":"68","author":"Li","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0165","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajpath.2018.11.010","article-title":"Loss of Wnt Secretion by Macrophages Promotes Hepatobiliary Injury after Administration of 3,5-Diethoxycarbonyl-1, 4-Dihydrocollidine Diet","volume":"189","author":"Jiang","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107328_b0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/00365521.2019.1611917","article-title":"Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study","volume":"54","author":"Eaton","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107328_b0175","doi-asserted-by":"crossref","first-page":"e74225","DOI":"10.1371\/journal.pone.0074225","article-title":"Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis","volume":"8","author":"Kawata","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.107328_b0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaut.2018.05.001","article-title":"Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice","volume":"91","author":"Hintermann","year":"2018","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0185","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cei.12193","article-title":"Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis","volume":"174","author":"Tanaka","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107328_b0190","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1189\/jlb.0313137","article-title":"Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils","volume":"94","author":"Licata","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0195","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s10620-014-3438-2","article-title":"Depletion of Foxp3+ Regulatory T Cells Promotes Profibrogenic Milieu of Cholestasis-Induced Liver Injury","volume":"60","author":"Roh","year":"2015","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.25662","article-title":"Regulatory T cells control the CD8 adaptive immune response at the time of ductal obstruction in experimental biliary atresia","volume":"56","author":"Lages","year":"2012","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.intimp.2020.107328_b0205","doi-asserted-by":"crossref","first-page":"e0136214","DOI":"10.1371\/journal.pone.0136214","article-title":"Dendritic cells regulate Treg-Th17 axis in obstructive phase of bile duct injury in murine biliary atresia","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.intimp.2020.107328_b0210","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1872-034X.2011.00832.x","article-title":"Diagnostic value of hepatic intercellular adhesion molecule-1 expression in Egyptian infants with biliary atresia and other forms of neonatal cholestasis","volume":"41","author":"Ghoneim","year":"2011","journal-title":"Hepatol Res."},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0215","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jat.3115","article-title":"T-helper cell-mediated factors in drug-induced liver injury","volume":"35","author":"Wang","year":"2015","journal-title":"J. Appl. Toxicol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107328_b0220","first-page":"516","article-title":"Study of relationship between T helper cell type-1 and type-2 cytokines and intrahepatic cholestasis of pregnancy","volume":"37","author":"Peng","year":"2002","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0225","first-page":"481","article-title":"Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living-donor liver transplantation","volume":"17","author":"Ueda","year":"2010","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1203\/01.PDR.0000130480.51066.FB","article-title":"Biliary atresia is associated with CD4(+) Th1 cell-mediated portal tract inflammation","volume":"56","author":"Mack","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.intimp.2020.107328_b0235","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.intimp.2018.09.027","article-title":"miR-181a regulates Th17 cells distribution via up-regulated BCL-2 in primary biliary cholangitis","volume":"64","author":"Song","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"44","key":"10.1016\/j.intimp.2020.107328_b0240","doi-asserted-by":"crossref","first-page":"e1888","DOI":"10.1097\/MD.0000000000001888","article-title":"The Distribution and the fibrotic role of elevated inflammatory Th17 cells in patients with primary biliary cirrhosis","volume":"94","author":"Shi","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"7090","key":"10.1016\/j.intimp.2020.107328_b0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0250","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00005-018-0515-9","article-title":"Deviations in Peripheral Blood Cell Populations are Associated with the Stage of Primary Biliary Cholangitis and Presence of Itching","volume":"66","author":"Cichoz-Lach","year":"2018","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0255","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0260","doi-asserted-by":"crossref","first-page":"e39307","DOI":"10.1371\/journal.pone.0039307","article-title":"Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0265","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0270","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaut.2010.06.004","article-title":"Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis","volume":"35","author":"Bernuzzi","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2020.107328_b0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2018.07.020","article-title":"Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-gamma secreting cells","volume":"94","author":"Liaskou","year":"2018","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.intimp.2020.107328_b0280","doi-asserted-by":"crossref","first-page":"e46241","DOI":"10.1371\/journal.pone.0046241","article-title":"Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-gamma, IL-2 and IL-2R","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28359","article-title":"Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study","volume":"64","author":"Hirschfield","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0290","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4049\/jimmunol.1004077","article-title":"Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis","volume":"187","author":"Katz","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107328_b0295","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.it.2013.01.001","article-title":"T follicular helper cell diversity and plasticity","volume":"34","author":"Cannons","year":"2013","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0300","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.27306","article-title":"CXCR5(+) CD4(+) T Follicular Helper Cells Participate in the Pathogenesis of Primary Biliary Cirrhosis","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"issue":"1.2","key":"10.1016\/j.intimp.2020.107328_b0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2152\/jmi.64.7","article-title":"Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms","volume":"64","author":"Tsuneyama","year":"2017","journal-title":"J. Med. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0310","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/sji.12616","article-title":"Dysregulation of Circulating Tfr\/Tfh Ratio in Primary biliary cholangitis","volume":"86","author":"Zheng","year":"2017","journal-title":"Scand. J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2020.107328_b0315","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni.2691","article-title":"Immune surveillance by the liver","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2020.107328_b0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0325","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0330","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0335","doi-asserted-by":"crossref","first-page":"G399","DOI":"10.1152\/ajpgi.00112.2018","article-title":"Role of the placenta in serum autotaxin elevation during maternal cholestasis","volume":"315","author":"Macias","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.intimp.2020.107328_b0340","doi-asserted-by":"crossref","first-page":"258164","DOI":"10.1155\/2013\/258164","article-title":"The role of TL1A and DR3 in autoimmune and inflammatory diseases","volume":"2013","author":"Aiba","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0345","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajpath.2011.10.026","article-title":"Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis","volume":"180","author":"Barrett","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107328_b0350","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/liv.12296","article-title":"Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis","volume":"34","author":"Aiba","year":"2014","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0355","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1189\/jlb.0812396","article-title":"Bile acids PKA-dependently induce a switch of the IL-10\/IL-12 ratio and reduce proinflammatory capability of human macrophages","volume":"94","author":"Haselow","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0360","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41598-017-18305-x","article-title":"Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids","volume":"8","author":"Wammers","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0365","doi-asserted-by":"crossref","DOI":"10.1177\/0192623312451160","article-title":"Effects of Kupffer cell depletion on acute alpha-naphthylisothiocyanate-induced liver toxicity in male mice","volume":"41","author":"Cullen","year":"2013","journal-title":"Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0370","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.22052","article-title":"Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis","volume":"47","author":"Chuang","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0375","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2220\/biomedres.35.161","article-title":"Increased activated natural killer T cells in the liver of patients with advanced stage primary biliary cirrhosis","volume":"35","author":"Aso-Ishimoto","year":"2014","journal-title":"Biomed. Res."},{"key":"10.1016\/j.intimp.2020.107328_b0380","doi-asserted-by":"crossref","first-page":"109579","DOI":"10.1016\/j.biopha.2019.109579","article-title":"The role of invariant natural killer T cells in experimental xenobiotic-induced cholestatic hepatotoxicity","volume":"122","author":"Nong","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2020.107328_b0385","doi-asserted-by":"crossref","first-page":"111777","DOI":"10.1016\/j.fct.2020.111777","article-title":"The role of invariant natural killer T cells and associated immunoregulatory factors in triptolide-induced cholestatic liver injury","volume":"146","author":"Zou","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0390","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jep.2014.06.006","article-title":"Triptolide: progress on research in pharmacodynamics and toxicology","volume":"155","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0395","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/j.gastro.2008.10.027","article-title":"Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage","volume":"136","author":"Wintermeyer","year":"2009","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.intimp.2020.107328_b0400","doi-asserted-by":"crossref","first-page":"e79702","DOI":"10.1371\/journal.pone.0079702","article-title":"Cross-activating invariant NKT cells and kupffer cells suppress cholestatic liver injury in a mouse model of biliary obstruction","volume":"8","author":"Duwaerts","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0405","doi-asserted-by":"crossref","first-page":"e11049","DOI":"10.1371\/journal.pone.0011049","article-title":"Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis","volume":"5","author":"Zimmermann","year":"2010","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.intimp.2020.107328_b0410","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10238-015-0381-2","article-title":"Elevated circulating CD14(low)CD16(+) monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization","volume":"16","author":"Peng","year":"2016","journal-title":"Clin Exp Med"},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0415","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/dmd.107.016907","article-title":"Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta","volume":"36","author":"Le Vee","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0420","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0425","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/jpet.113.205369","volume":"347","author":"Bodeman","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0430","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis","volume":"178","author":"Allen","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0435","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/toxsci\/kfr311","article-title":"Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice","volume":"126","author":"Sullivan","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2020.107328_b0440","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/jphp.13008","article-title":"Paeonia lactiflora Pall. regulates the NF-kappaB-NLRP3 inflammasome pathway to alleviate cholestasis in rats","volume":"70","author":"Ma","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020289","article-title":"Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway","volume":"18","author":"Kempinska-Podhorodecka","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0450","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-1007181","article-title":"Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules","volume":"17","author":"Nakanuma","year":"1997","journal-title":"Semin. Liver Dis."},{"issue":"6","key":"10.1016\/j.intimp.2020.107328_b0455","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0168-8278(96)80292-3","article-title":"Increased intercellular adhesion molecule-1 serum concentration in cholestasis","volume":"25","author":"Polzien","year":"1996","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0460","doi-asserted-by":"crossref","first-page":"G499","DOI":"10.1152\/ajpgi.00318.2003","article-title":"Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice","volume":"286","author":"Gujral","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107328_b0465","first-page":"6249","article-title":"MicroRNAs derived from urinary exosomes act as novel biomarkers in the diagnosis of intrahepatic cholestasis of pregnancy","volume":"11","author":"Jiang","year":"2019","journal-title":"Am J Transl Res"},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020342","article-title":"Mechanisms of Regulation of the Chemokine-Receptor Network","volume":"18","author":"Stone","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0475","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2005.08.009","article-title":"Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives","volume":"25","author":"Chuang","year":"2005","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.intimp.2020.107328_b0480","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep4.1170","article-title":"NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid","volume":"2","author":"de Graaf","year":"2018","journal-title":"Hepatol Commun"},{"issue":"9","key":"10.1016\/j.intimp.2020.107328_b0485","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ni.2079","article-title":"Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells","volume":"12","author":"Feau","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.107328_b0490","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12026-014-8594-0","article-title":"Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease","volume":"61","author":"Agmon-Levin","year":"2015","journal-title":"Immunol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0495","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10620-018-5351-6","article-title":"Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis","volume":"64","author":"Czaja","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2020.107328_b0500","first-page":"595","article-title":"Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line","volume":"59","author":"Ellis","year":"1986","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.intimp.2020.107328_b0505","first-page":"779","article-title":"Relationship of human leucocyte antigen G, E with intrahepatic cholestasis of pregnancy","volume":"38","author":"Peng","year":"2007","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0510","article-title":"Expression of human leucocyte antigen F in human placenta and its relationship with intrahepatic cholestasis of pregnancy","volume":"31","author":"Ming Li","year":"2015","journal-title":"Journal of PracticalObstetrics and Gynecology"},{"issue":"23","key":"10.1016\/j.intimp.2020.107328_b0515","first-page":"3539","article-title":"Hua Pan and Jing Zhang, Expression and significance of HLA-F in placenta of patients with ICP","volume":"39","author":"Lijuan Yang","year":"2017","journal-title":"Hebei Medical Journal"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0520","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","article-title":"SIRT1 and other sirtuins in metabolism","volume":"25","author":"Chang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2020.107328_b0525","doi-asserted-by":"crossref","first-page":"8765954","DOI":"10.1155\/2019\/8765954","article-title":"SIRT1 Modulators in Experimentally Induced Liver Injury","volume":"2019","author":"Farghali","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/j.intimp.2020.107328_b0530","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bbrc.2019.03.131","article-title":"Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPAR\u03b1","volume":"512","author":"Yang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2020.107328_b0535","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41401-018-0110-y","article-title":"18\u03b2-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1\/FXR signaling pathway","volume":"39","author":"Wu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"22","key":"10.1016\/j.intimp.2020.107328_b0540","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon","year":"1991","journal-title":"UDCA-PBC Study Group, N Engl J Med"},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2020.107328_b0545","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR","volume":"62","author":"Beuers","year":"2015","journal-title":"PXR and beyond, J Hepatol"},{"issue":"4","key":"10.1016\/j.intimp.2020.107328_b0550","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0555","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.intimp.2020.107328_b0560","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2020.107328_b0565","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0570","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.510310209","article-title":"Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid","volume":"31","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0575","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bcp.12480","article-title":"Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy","volume":"79","author":"Esti\u00fa","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0580","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1096\/fj.201900015RR","article-title":"Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta","volume":"33","author":"Lofthouse","year":"2019","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.intimp.2020.107328_b0585","doi-asserted-by":"crossref","first-page":"G923","DOI":"10.1152\/ajpgi.00490.2005","article-title":"Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha\/beta in the adaptive response to bile acids","volume":"290","author":"Zollner","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0590","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa","year":"1992","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0595","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.gastro.2005.06.019","article-title":"Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy","volume":"129","author":"Kondrackiene","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2020.107328_b0600","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1471-0528.1995.tb09077.x","article-title":"Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy","volume":"102","author":"Sadler","year":"1995","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0605","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1701-2163(15)30544-2","article-title":"The Effects of Ursodeoxycholic Acid Treatment for Intrahepatic Cholestasis of Pregnancy on Maternal and Fetal Outcomes: A Meta-Analysis Including Non-Randomized Studies","volume":"36","author":"Grand\u2019Maison","year":"2014","journal-title":"J. Obstetrics Gynaecol. Canada"},{"issue":"7","key":"10.1016\/j.intimp.2020.107328_b0610","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1701-2163(15)30544-2","article-title":"The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies","volume":"36","author":"Grand'Maison","year":"2014","journal-title":"J. Obstet Gynaecol. Can."},{"issue":"9","key":"10.1016\/j.intimp.2020.107328_b0615","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.intimp.2020.107328_b0620","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.intimp.2020.107328_b0625","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrgastro.2014.148","article-title":"Liver: a variant of FGF19 protects the liver from cholestatic injury without inducing cancer","volume":"11","author":"Patman","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"247","key":"10.1016\/j.intimp.2020.107328_b0630","doi-asserted-by":"crossref","first-page":"247ra100","DOI":"10.1126\/scitranslmed.3009098","article-title":"A nontumorigenic variant of FGF19 treats cholestatic liver diseases","volume":"6","author":"Luo","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0635","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000341420","article-title":"Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans","volume":"86","author":"Marschall","year":"2012","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0640","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile Acids as Hormones: The FXR-FGF15\/19 Pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0645","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.30509","article-title":"The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis","volume":"70","author":"Trauner","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0650","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.24113","article-title":"Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis","volume":"53","author":"Wu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2020.107328_b0655","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.3389\/fimmu.2019.02633","article-title":"Constitutive Activation of Natural Killer Cells in Primary Biliary Cholangitis","volume":"10","author":"Hydes","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.107328_b0660","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-020-05111-6","article-title":"Role of cell autophagy in the generation of IgM and hepatic fibrosis in primary biliary cholangitis","author":"Lian","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0665","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00404-018-4850-1","article-title":"Magnesium sulphate can alleviate oxidative stress and reduce inflammatory cytokines in rat placenta of intrahepatic cholestasis of pregnancy model","volume":"298","author":"Han","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"12","key":"10.1016\/j.intimp.2020.107328_b0670","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/aps.2014.119","article-title":"Resveratrol effectively attenuates \u03b1-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms","volume":"35","author":"Wang","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.intimp.2020.107328_b0675","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/hepr.13198","article-title":"Resveratrol regulates the silent information regulator 1-nuclear factor-kappaB signaling pathway in intrahepatic cholestasis of pregnancy","volume":"48","author":"Liao","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.intimp.2020.107328_b0680","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1752-0509-3-31","article-title":"Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo","volume":"3","author":"Smith","year":"2009","journal-title":"BMC Syst. Biol."},{"issue":"7170","key":"10.1016\/j.intimp.2020.107328_b0685","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature06261","article-title":"Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes","volume":"450","author":"Milne","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2020.107328_b0690","doi-asserted-by":"crossref","first-page":"152948","DOI":"10.1016\/j.phymed.2019.152948","article-title":"Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice","volume":"62","author":"Li","year":"2019","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.intimp.2020.107328_b0695","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/FJC.0000000000000406","article-title":"Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial","volume":"68","author":"Panahi","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107328_b0700","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12876-019-1055-4","article-title":"Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial","volume":"19","author":"Saadati","year":"2019","journal-title":"BMC Gastroenterol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920337954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920337954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:23:59Z","timestamp":1761585839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920337954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":137,"alternative-id":["S1567576920337954"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107328","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An insight into the mechanism and molecular basis of dysfunctional immune response involved in cholestasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107328"}}